Prakash Ramalingam1, Young Tag Ko. 1. College of Pharmacy, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, 406-799, South Korea.
Abstract
PURPOSE: Solid lipid nanoparticles (SLNs) have been proposed as a colloidal carrier system that could enhance the oral bioavailability of curcumin. However, a burst release of the loaded drug, which occurs in acidic environments, has been a main obstacle to the oral delivery of curcumin by using SLNs as a carrier system. We hypothesized that a quarternized chitosan derivative could be used for acid-resistant coating to stabilize the SLNs and circumvent the burst release. METHODS: N-trimethyl chitosan (TMC) was synthesized and determined by (1)H-NMR and FT-IR. To investigate the details of chitosan and TMC surface modification on SLCNs composed of palmitic acid, cholesterol, TPGS and curcumin, a number of factors such as optimized SLNs composition, solid state characterization, stability, cell viability, in vitro release in GI conditions, curcumin oral bioavailability and brain distribution studies, were evaluated. RESULTS: The TMC-SLCNs exhibited prolonged stability in room and refrigerated conditions, controlled drug release in simulated intestinal fluid, significantly higher oral bioavailability, and brain distribution of curcumin than free curcumin, chitosan and non-coated SLCNs. CONCLUSIONS: These finding suggests that the TMC-SLCNs is a promising nanocarrier system for oral delivery and brain distribution of curcumin.
PURPOSE: Solid lipid nanoparticles (SLNs) have been proposed as a colloidal carrier system that could enhance the oral bioavailability of curcumin. However, a burst release of the loaded drug, which occurs in acidic environments, has been a main obstacle to the oral delivery of curcumin by using SLNs as a carrier system. We hypothesized that a quarternized chitosan derivative could be used for acid-resistant coating to stabilize the SLNs and circumvent the burst release. METHODS:N-trimethyl chitosan (TMC) was synthesized and determined by (1)H-NMR and FT-IR. To investigate the details of chitosan and TMC surface modification on SLCNs composed of palmitic acid, cholesterol, TPGS and curcumin, a number of factors such as optimized SLNs composition, solid state characterization, stability, cell viability, in vitro release in GI conditions, curcumin oral bioavailability and brain distribution studies, were evaluated. RESULTS: The TMC-SLCNs exhibited prolonged stability in room and refrigerated conditions, controlled drug release in simulated intestinal fluid, significantly higher oral bioavailability, and brain distribution of curcumin than free curcumin, chitosan and non-coated SLCNs. CONCLUSIONS: These finding suggests that the TMC-SLCNs is a promising nanocarrier system for oral delivery and brain distribution of curcumin.
Authors: Oliver Germershaus; Shirui Mao; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel Journal: J Control Release Date: 2007-10-23 Impact factor: 9.776
Authors: S Cafaggi; E Russo; R Stefani; R Leardi; G Caviglioli; B Parodi; G Bignardi; D De Totero; C Aiello; M Viale Journal: J Control Release Date: 2007-06-12 Impact factor: 9.776
Authors: Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Paula B Luis; Claus Schneider; Janet L Funk Journal: J Nutr Biochem Date: 2018-10-11 Impact factor: 6.048
Authors: Maria João Ramalho; Stephanie Andrade; Joana Angélica Loureiro; Maria do Carmo Pereira Journal: Drug Deliv Transl Res Date: 2020-04 Impact factor: 4.617
Authors: Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk Journal: J Nat Prod Date: 2019-02-22 Impact factor: 4.050